ADIPOQ and asthma: The strongest evidence supporting a relationship between adiponectin and asthma comes from a US-based longitudinal cohort that showed that low serum total adiponectin concentrations (<7 mg/L) are associated with increased risk for incident asthma among women and that this association was significantly stronger among current smokers versus not currently smoking women [69].